Peng Zhou

Title: Peng Zhou: Innovator in Pharmaceutical Chemistry

Introduction

Peng Zhou is a notable inventor based in Changzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel crystalline forms of compounds that have therapeutic applications.

Latest Patents

Peng Zhou holds 2 patents that focus on innovative crystalline forms of specific chemical compounds. His latest patents include the monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one. This patent relates to crystalline polymorph forms that are essential for enhancing the efficacy of the compound. Another significant patent involves a crystalline form of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1H-pyrazole-4-carboxamide monohydrate. This invention is particularly useful in the treatment of MALT-1 related diseases.

Career Highlights

Throughout his career, Peng Zhou has worked with prominent companies in the pharmaceutical industry. He has been associated with Cardurion Pharmaceuticals, LLC and Janssen Pharmaceutica NV, where he has contributed to various research and development projects.

Collaborations

Peng Zhou has collaborated with notable professionals in his field, including Haojuan Wei and Kristof Leonard Kimpe. These collaborations have further enriched his research and innovation efforts.

Conclusion

Peng Zhou is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in drug development. His innovative patents and collaborations highlight his commitment to improving therapeutic options for patients.